-
1
-
-
0027940611
-
Control of prostate cancer with radiotherapy: Long-term results
-
Bagshaw MA, Cox RS, Hancock SL. Control of prostate cancer with radiotherapy: long-term results. J Urol 1994;152:1781-1785.
-
(1994)
J Urol
, vol.152
, pp. 1781-1785
-
-
Bagshaw, M.A.1
Cox, R.S.2
Hancock, S.L.3
-
2
-
-
0028125318
-
Five-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
-
Catalona WJ, Smith DS. Five-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-1842.
-
(1994)
J Urol
, vol.152
, pp. 1837-1842
-
-
Catalona, W.J.1
Smith, D.S.2
-
3
-
-
0023786089
-
Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of postirradiation prostate biopsy
-
Scardino PT, Wheeler TM. Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy. NCI Monogr 1988; 7:95-103.
-
(1988)
NCI Monogr
, vol.7
, pp. 95-103
-
-
Scardino, P.T.1
Wheeler, T.M.2
-
4
-
-
0026590417
-
The importance of local control in the treatment of prostatic cancer
-
Kaplan ID, Prestidge BR, Bagshaw MA, Cox RS. The importance of local control in the treatment of prostatic cancer. J Urol 1992; 147:917-921.
-
(1992)
J Urol
, vol.147
, pp. 917-921
-
-
Kaplan, I.D.1
Prestidge, B.R.2
Bagshaw, M.A.3
Cox, R.S.4
-
6
-
-
0020579353
-
Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, stage III, predict long-term survival?
-
Cox JD, Kline RW. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, stage III, predict long-term survival? Int J Radiat Oncol Biol Phys 1983;9:299-303.
-
(1983)
Int J Radiat Oncol Biol Phys
, vol.9
, pp. 299-303
-
-
Cox, J.D.1
Kline, R.W.2
-
7
-
-
0025316548
-
Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up
-
Amdur RJ, Parsons JT, Fitzgerald LT, Million RR. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up. Radiother Oncol 1990;18: 235-246.
-
(1990)
Radiother Oncol
, vol.18
, pp. 235-246
-
-
Amdur, R.J.1
Parsons, J.T.2
Fitzgerald, L.T.3
Million, R.R.4
-
8
-
-
0021830101
-
ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer
-
Hanks GE. ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer. Int J Radiat Oncol Biol Phys 1985;11:1235-1245.
-
(1985)
Int J Radiat Oncol Biol Phys
, vol.11
, pp. 1235-1245
-
-
Hanks, G.E.1
-
9
-
-
0021942138
-
Potential for radiotherapy alone in prostatic cancer
-
Bagshaw MA. Potential for radiotherapy alone in prostatic cancer. Cancer 1985;55:2079-2085.
-
(1985)
Cancer
, vol.55
, pp. 2079-2085
-
-
Bagshaw, M.A.1
-
10
-
-
0029013018
-
Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation
-
Hanks GE, Lee WR, Schultheiss TE. Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. J Urol 1995;154:456-459.
-
(1995)
J Urol
, vol.154
, pp. 456-459
-
-
Hanks, G.E.1
Lee, W.R.2
Schultheiss, T.E.3
-
11
-
-
0028029809
-
Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: Interim report of a phase 1 dose-escalation study
-
Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. J Urol 1994;152:1792-1798.
-
(1994)
J Urol
, vol.152
, pp. 1792-1798
-
-
Leibel, S.A.1
Zelefsky, M.J.2
Kutcher, G.J.3
Burman, C.M.4
Kelson, S.5
Fuks, Z.6
-
12
-
-
0017664747
-
Experimental models for the study of prostatic adenocarcinoma
-
Smolev JK, Coffey DS, Scott WW. Experimental models for the study of prostatic adenocarcinoma. J Urol 1977;118:216-220.
-
(1977)
J Urol
, vol.118
, pp. 216-220
-
-
Smolev, J.K.1
Coffey, D.S.2
Scott, W.W.3
-
13
-
-
0019841416
-
Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma
-
Isaacs JT, Coffey DS. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res 1981;41:5070-5075.
-
(1981)
Cancer Res
, vol.41
, pp. 5070-5075
-
-
Isaacs, J.T.1
Coffey, D.S.2
-
14
-
-
0027930456
-
Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma
-
Landström M, Damber J-E, Bergh A. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma. Prostate 1994;25:10-18.
-
(1994)
Prostate
, vol.25
, pp. 10-18
-
-
Landström, M.1
Damber, J.-E.2
Bergh, A.3
-
15
-
-
0018873123
-
Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327)
-
Camuzzi F, Block NL, Stover B, Gottlieb C, Charyulu K, Politano VA. Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adenocarcinoma (R-3327). Urology 1980;15:443-447.
-
(1980)
Urology
, vol.15
, pp. 443-447
-
-
Camuzzi, F.1
Block, N.L.2
Stover, B.3
Gottlieb, C.4
Charyulu, K.5
Politano, V.A.6
-
16
-
-
0025891334
-
Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu)
-
Rao BR, Slotman BJ, Geldof AA, Perez CA. Radiation sensitivity of Copenhagen rat prostatic carcinoma (R3327-AT and R3327-MATLyLu). Int J Radiat Oncol Biol Phys 1991;20:981-9855.
-
(1991)
Int J Radiat Oncol Biol Phys
, vol.20
, pp. 981-9855
-
-
Rao, B.R.1
Slotman, B.J.2
Geldof, A.A.3
Perez, C.A.4
-
17
-
-
0021833233
-
The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas
-
Thorndyke C, Meeker BE, Thomas G, Lakey VVH, McPhee MS, Chapman JD. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas. J Urol 1985;134:191-198.
-
(1985)
J Urol
, vol.134
, pp. 191-198
-
-
Thorndyke, C.1
Meeker, B.E.2
Thomas, G.3
Lakey, V.V.H.4
McPhee, M.S.5
Chapman, J.D.6
-
18
-
-
0019918990
-
Response of the Dunning R3327H prostatic adenocarcinoma to radiation and various chemotherapeutic drugs
-
Mador D, Ritchie B, Meeker B, Moore R, Elliott FG, McPhee MS, Chapman JD, Lakey WH. Response of the Dunning R3327H prostatic adenocarcinoma to radiation and various chemotherapeutic drugs. Cancer Treat Rep 1982;66:1837-1843.
-
(1982)
Cancer Treat Rep
, vol.66
, pp. 1837-1843
-
-
Mador, D.1
Ritchie, B.2
Meeker, B.3
Moore, R.4
Elliott, F.G.5
McPhee, M.S.6
Chapman, J.D.7
Lakey, W.H.8
-
19
-
-
0025045224
-
Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma
-
Landstrom M, Bergh A, Tomic R, Damber J-E. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate 1990;17:57-68.
-
(1990)
Prostate
, vol.17
, pp. 57-68
-
-
Landstrom, M.1
Bergh, A.2
Tomic, R.3
Damber, J.-E.4
|